Cargando…
Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background
Subacute thyroiditis (SAT) is a thyroid inflammatory disease whose pathogenesis is still not completely defined. Previous viral infection is considered to be a triggering factor in genetically predisposed individuals. In about 70% of patients, susceptibility to SAT is associated with the HLA-B*35 al...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074389/ https://www.ncbi.nlm.nih.gov/pubmed/32079059 http://dx.doi.org/10.3390/jcm9020534 |
_version_ | 1783506821935267840 |
---|---|
author | Stasiak, Magdalena Tymoniuk, Bogusław Michalak, Renata Stasiak, Bartłomiej Kowalski, Marek L. Lewiński, Andrzej |
author_facet | Stasiak, Magdalena Tymoniuk, Bogusław Michalak, Renata Stasiak, Bartłomiej Kowalski, Marek L. Lewiński, Andrzej |
author_sort | Stasiak, Magdalena |
collection | PubMed |
description | Subacute thyroiditis (SAT) is a thyroid inflammatory disease whose pathogenesis is still not completely defined. Previous viral infection is considered to be a triggering factor in genetically predisposed individuals. In about 70% of patients, susceptibility to SAT is associated with the HLA-B*35 allele. The correlation between SAT and other human leukocyte antigens (HLA) has not yet been unequivocally demonstrated and the genetic background is still unknown in about 30% of patients. The purpose of our study was to perform HLA genotyping using a next-generation sequencing method, to find out whether alleles other than HLA-B*35 are correlated with SAT morbidity. HLA-A, -B, -C, -DQB1, -DRB1 were genotyped using a next-generation sequencing method in 1083 subjects, including 60 SAT patients and 1023 healthy controls. Among 60 patients diagnosed with SAT, 81.7% of subjects were identified as having allele HLA-B*35, 23.3% had HLA-B*18:01, 28.3% had HLA-DRB1*01 and 75.5% had HLA-C*04:01. These alleles occurred in the control group at frequencies of 10.2%, 7.2%, 12.9% and 12.5%, respectively. The differences were statistically significant, with p < 0.05. In addition to its previously described relationship with HLA-B*35, genetic susceptibility to SAT was associated with the presence of HLA-B*18:01, DRB1*01 and C*04:01. The alleles HLA-B*18:01 and DRB1*01 were independent SAT risk factors. The assessment of these four alleles allows the confirmation of genetic predisposition in almost all patients with SAT. |
format | Online Article Text |
id | pubmed-7074389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70743892020-03-20 Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background Stasiak, Magdalena Tymoniuk, Bogusław Michalak, Renata Stasiak, Bartłomiej Kowalski, Marek L. Lewiński, Andrzej J Clin Med Article Subacute thyroiditis (SAT) is a thyroid inflammatory disease whose pathogenesis is still not completely defined. Previous viral infection is considered to be a triggering factor in genetically predisposed individuals. In about 70% of patients, susceptibility to SAT is associated with the HLA-B*35 allele. The correlation between SAT and other human leukocyte antigens (HLA) has not yet been unequivocally demonstrated and the genetic background is still unknown in about 30% of patients. The purpose of our study was to perform HLA genotyping using a next-generation sequencing method, to find out whether alleles other than HLA-B*35 are correlated with SAT morbidity. HLA-A, -B, -C, -DQB1, -DRB1 were genotyped using a next-generation sequencing method in 1083 subjects, including 60 SAT patients and 1023 healthy controls. Among 60 patients diagnosed with SAT, 81.7% of subjects were identified as having allele HLA-B*35, 23.3% had HLA-B*18:01, 28.3% had HLA-DRB1*01 and 75.5% had HLA-C*04:01. These alleles occurred in the control group at frequencies of 10.2%, 7.2%, 12.9% and 12.5%, respectively. The differences were statistically significant, with p < 0.05. In addition to its previously described relationship with HLA-B*35, genetic susceptibility to SAT was associated with the presence of HLA-B*18:01, DRB1*01 and C*04:01. The alleles HLA-B*18:01 and DRB1*01 were independent SAT risk factors. The assessment of these four alleles allows the confirmation of genetic predisposition in almost all patients with SAT. MDPI 2020-02-16 /pmc/articles/PMC7074389/ /pubmed/32079059 http://dx.doi.org/10.3390/jcm9020534 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stasiak, Magdalena Tymoniuk, Bogusław Michalak, Renata Stasiak, Bartłomiej Kowalski, Marek L. Lewiński, Andrzej Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background |
title | Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background |
title_full | Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background |
title_fullStr | Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background |
title_full_unstemmed | Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background |
title_short | Subacute Thyroiditis is Associated with HLA-B*18:01, -DRB1*01 and -C*04:01—The Significance of the New Molecular Background |
title_sort | subacute thyroiditis is associated with hla-b*18:01, -drb1*01 and -c*04:01—the significance of the new molecular background |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074389/ https://www.ncbi.nlm.nih.gov/pubmed/32079059 http://dx.doi.org/10.3390/jcm9020534 |
work_keys_str_mv | AT stasiakmagdalena subacutethyroiditisisassociatedwithhlab1801drb101andc0401thesignificanceofthenewmolecularbackground AT tymoniukbogusław subacutethyroiditisisassociatedwithhlab1801drb101andc0401thesignificanceofthenewmolecularbackground AT michalakrenata subacutethyroiditisisassociatedwithhlab1801drb101andc0401thesignificanceofthenewmolecularbackground AT stasiakbartłomiej subacutethyroiditisisassociatedwithhlab1801drb101andc0401thesignificanceofthenewmolecularbackground AT kowalskimarekl subacutethyroiditisisassociatedwithhlab1801drb101andc0401thesignificanceofthenewmolecularbackground AT lewinskiandrzej subacutethyroiditisisassociatedwithhlab1801drb101andc0401thesignificanceofthenewmolecularbackground |